(Q30664229)

26 June 2017

1 reference

title

Imaging and neurochemical markers for diagnosis and disease progression in ALS. (English)

1 reference

amyotrophic lateral sclerosis

26 June 2017

main subject

1 reference

Karitzky J

1

1 reference

26 June 2017

Ludolph AC

series ordinal

2

1 reference

26 June 2017

publication date

1 October 2001

1 reference

Journal of the Neurological Sciences

26 June 2017

published in

1 reference

26 June 2017

volume

191

1 reference

26 June 2017

issue

1-2

1 reference

26 June 2017

page(s)

35-41

1 reference

Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

An analysis of extended survival in patients with amyotrophic lateral sclerosis treated with riluzole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Huntington's disease. In reverse gear

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

7 January 2021

Motor neurone disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Methods for discerning disease-modifying effects in Alzheimer disease treatment trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points: a meta-analysis. HIV Surrogate Marker Collaborative Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Patterns of brain activation in people at risk for Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Amyotrophic lateral sclerosis: correlation of clinical and MR imaging findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Focal signal-intensity variations in the posterior internal capsule: normal MR findings and distinction from pathologic findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Diffusion tensor MRI assesses corticospinal tract damage in ALS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Motor neuron diseases: comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Cerebral atrophy in motor neuron disease evaluated by computed tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Frontal lobe atrophy in motor neuron diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Echo-planar time course MRI of cat brain oxygenation changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Magnetic resonance spectroscopy in toxic encephalopathy and neurodegeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

1H-MRS evidence of neurodegeneration and excess glutamate + glutamine in ALS medulla

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

TechSight. Imaging. A molecular map for neurodegeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Clinical and [18F] dopa PET findings in early Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Lowered cerebral glucose utilization in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Cortical motor-sensory hypometabolism in amyotrophic lateral sclerosis: a PET study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis. A neuropsychological and positron emission tomography study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Cortical function in amyotrophic lateral sclerosis. A positron emission tomography study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Extramotor involvement in ALS: PET studies with the GABAA ligand [11C]flumazenil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Decrease of S100 beta protein in serum of patients with amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Glutamine synthetase in cerebrospinal fluid, serum, and brain: a diagnostic marker for Alzheimer disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Abnormal glutamate metabolism in amyotrophic lateral sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Glutamate, excitotoxicity and amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

The RNA of the glutamate transporter EAAT2 is variably spliced in amyotrophic lateral sclerosis and normal individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Glutamate transporter EAAT2 splice variants occur not only in ALS, but also in AD and controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Genetics of amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Remarkable increase in cerebrospinal fluid 3-nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Nitration of manganese superoxide dismutase in cerebrospinal fluids is a marker for peroxynitrite-mediated oxidative stress in neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Linkage of the gene for an autosomal dominant form of juvenile amyotrophic lateral sclerosis to chromosome 9q34.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Linkage of recessive familial amyotrophic lateral sclerosis to chromosome 2q33-q35.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Linkage of a commoner form of recessive amyotrophic lateral sclerosis to chromosome 15q15-q22 markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

Experimental therapeutics of neurodegenerative disorders: unmet needs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900628-1

10.1016/S0022-510X(01)00628-1

7 January 2021

Identifiers

DOI

1 reference

26 June 2017

1 reference